Molecular bases of the cellular handling of vitamin C: Transport and metabolism in health and disease

Handbook of Vitamin C Research: Daily Requirements, Dietary Sources and Adverse Effects

Volumn , Issue , 2009, Pages 213-236

  Marin, J J G ^a   Serrano, M A ^a   Perez, M J ^a   Macias, R I R ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896406114     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (131)

1. Agus DB, Gambhir SS, Pardridge WM, Spielholz C, Baselga J, Vera JC & Golde DW. (1997). Vitamin C crosses the blood-brain barrier in the oxidized form through the glucose transporters. J Clin Invest 100, 2842-2848.
2. Anderson R, Theron AJ & Ras GJ. (1988). Ascorbic acid neutralizes reactive oxidants released by hyperactive phagocytes from cigarette smokers. Lung 166, 149-159.
3. Banhegyi G, Csala M, Braun L, Garzo T & Mandl J. (1996). Ascorbate synthesisdependent glutathione consumption in mouse liver. FEBS Lett 381, 39-41.
4. Basu TK & Schorah CJ. (1982). Vitamin C in Health and Disease. Croom Helm Ltd., London.
5. Biondi C, Pavan B, Dalpiaz A, Medici S, Lunghi L & Vesce F. (2007). Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. Mol Hum Reprod 13, 77-83.
6. Blee TH, Cogbill TH & Lambert PJ. (2002). Hemorrhage associated with vitamin C deficiency in surgical patients. Surgery 131, 408-412.
7. Block G. (1991). Epidemiologic evidence regarding vitamin C and cancer. Am J Clin Nutr 54, 1310S-1314S.
8. Block G. (1992). The data support a role for antioxidants in reducing cancer risk. Nutr Rev 50, 207-213.
9. Bode AM, Cunningham L & Rose RC. (1990). Spontaneous decay of oxidized ascorbic acid (dehydro-L-ascorbic acid) evaluated by high-pressure liquid chromatography. Clin Chem 36, 1807-1809.
10. Borrelli E, Roux-Lombard P, Grau GE, Girardin E, Ricou B, Dayer J & Suter PM. (1996). Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med 24, 392-397.
11. Bossuyt X & Blanckaert N. (1995). Mechanism of stimulation of microsomal UDPglucuronosyltransferase by UDP-N-acetylglucosamine. Biochem J 305 ( Pt 1), 321-328.
12. Bouhuys A. (1974). Letter: Colds and antihistaminic effects of vitamin C. N Engl J Med 290, 633.
13. Boyer JC, Campbell CE, Sigurdson WJ & Kuo SM. (2005). Polarized localization of vitamin C transporters, SVCT1 and SVCT2, in epithelial cells. Biochem Biophys Res Commun 334, 150-156.
14. Braddock R, Siman CM, Hamilton K, Garland HO & Sibley CP. (2002). Gammalinoleic acid and ascorbate improves skeletal ossification in offspring of diabetic rats. Pediatr Res 51, 647-652.
15. Bron AJ & Brown NA. (1987). Perinuclear lens retrodots: a role for ascorbate in cataractogenesis. Br J Ophthalmol 71, 86-95.
16. Brubacher D, Moser U & Jordan P. (2000). Vitamin C concentrations in plasma as a function of intake: a meta-analysis. Int J Vitam Nutr Res 70, 226-237.
17. Bublitz C & Lehninger AL. (1959). The enzymic conversion of L-gulonate to L-ascorbate by rat-liver enzymes. Biochim Biophys Acta 32, 290-291.
18. Chatterjee IB, Chatterjee GC, Ghosh NC, Ghosh JJ & Guha BC. (1960). Biological synthesis of L-ascorbic acid in animal tissues: conversion of D-glucuronolactone and L-gulonolactone into L-ascorbic acid. Biochem J 76, 279-292.
19. Clark AG, Rohrbaugh AL, Otterness I & Kraus VB. (2002). The effects of ascorbic acid on cartilage metabolism in guinea pig articular cartilage explants. Matrix Biol 21, 175-184.
20. Cochrane CG, Spragg R & Revak SD. (1983). Pathogenesis of the adult respiratory distress syndrome. Evidence of oxidant activity in bronchoalveolar lavage fluid. J Clin Invest 71, 754-761.
21. Cunningham JJ, Ellis SL, McVeigh KL, Levine RE & Calles-Escandon J. (1991). Reduced mononuclear leukocyte ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate dietary vitamin C. Metabolism 40, 146-149.
22. Daruwala R, Song J, Koh WS, Rumsey SC & Levine M. (1999). Cloning and functional characterization of the human sodium-dependent vitamin C transporters hSVCT1 and hSVCT2. FEBS Lett 460, 480-484.
23. Daskalopoulos R, Korcok J, Tao L & Wilson JX. (2002). Accumulation of intracellular ascorbate from dehydroascorbic acid by astrocytes is decreased after oxidative stress and restored by propofol. Glia 39, 124-132.
24. Dekkers JC, van Doornen LJ & Kemper HC. (1996). The role of antioxidant vitamins and enzymes in the prevention of exercise-induced muscle damage. Sports Med 21, 213-238.
25. Demling R, Ikegami K, Picard L & Lalonde C. (1994). Administration of large doses of vitamin C does not decrease oxidant-induced lung lipid peroxidation caused by bacterial-independent acute peritonitis. Inflammation 18, 499-510.
26. Dhariwal KR, Hartzell WO & Levine M. (1991). Ascorbic acid and dehydroascorbic acid measurements in human plasma and serum. Am J Clin Nutr 54, 712-716.
27. Faaland CA, Race JE, Ricken G, Warner FJ, Williams WJ & Holtzman EJ. (1998). Molecular characterization of two novel transporters from human and mouse kidney and from LLC-PK1 cells reveals a novel conserved family that is homologous to bacterial and Aspergillus nucleobase transporters. Biochim Biophys Acta 1442, 353-360.
28. Fain O, Paries J, Jacquart B, Le Moel G, Kettaneh A, Stirnemann J, Heron C, Sitbon M, Taleb C, Letellier E, Betari B, Gattegno L & Thomas M. (2003). Hypovitaminosis C in hospitalized patients. Eur J Intern Med 14, 419-425.
29. Feiz HR & Mobarhan S. (2002). Does vitamin C intake slow the progression of gastric cancer in Helicobacter pylori-infected populations? Nutr Rev 60, 34-36.
30. Finley EB & Cerklewski FL. (1983). Influence of ascorbic acid supplementation on copper status in young adult men. Am J Clin Nutr 37, 553-556.
31. Fischer H, Schwarzer C & Illek B. (2004). Vitamin C controls the cystic fibrosis transmembrane conductance regulator chloride channel. Proc Natl Acad Sci U S A 101, 3691-3696.
32. Fishbein SL & Goodstein S. (1972). The pressure lowering effect of ascorbic acid. Ann Ophthalmol 4, 487-491.
33. Franceschi RT, Wilson JX & Dixon SJ. (1995). Requirement for Na(+)-dependent ascorbic acid transport in osteoblast function. Am J Physiol 268, C1430-1439.
34. Frei B. (1991). Ascorbic acid protects lipids in human plasma and low-density lipoprotein against oxidative damage. Am J Clin Nutr 54, 1113S-1118S.
35. Frei B. (1994). Reactive oxygen species and antioxidant vitamins: mechanisms of action. Am J Med 97, 5S-13S; discussion 22S-28S.
36. Frei B, England L & Ames BN. (1989). Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci U S A 86, 6377-6381.
37. Fujita I, Hirano J, Itoh N, Nakanishi T & Tanaka K. (2001). Dexamethasone induces sodium-dependant vitamin C transporter in a mouse osteoblastic cell line MC3T3-E1. Br J Nutr 86, 145-149.
38. Fujita T, Uchida K & Maruyama N. (1992). Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1116, 122-128.
39. Gale CR, Martyn CN, Winter PD & Cooper C. (1995). Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 310, 1563-1566.
40. Geber WF, Lefkowitz SS & Hung CY. (1975). Effect of ascorbic acid, sodium salicylate, and caffeine on the serum interferon level in response to viral infection. Pharmacology 13, 228-233.
41. Gerster H. (1997). No contribution of ascorbic acid to renal calcium oxalate stones. Ann Nutr Metab 41, 269-282.
42. Halliwell B, Wasil M & Grootveld M. (1987). Biologically significant scavenging of the myeloperoxidase-derived oxidant hypochlorous acid by ascorbic acid. Implications for antioxidant protection in the inflamed rheumatoid joint. FEBS Lett 213, 15-17.
43. Handschin C & Meyer UA. (2005). Regulatory network of lipid-sensing nuclear receptors: roles for CAR, PXR, LXR, and FXR. Arch Biochem Biophys 433, 387-396.
44. Hankinson SE, Stampfer MJ, Seddon JM, Colditz GA, Rosner B, Speizer FE & Willett WC. (1992). Nutrient intake and cataract extraction in women: a prospective study. BMJ 305, 335-339.
45. Hegde KR & Varma SD. (2004). Protective effect of ascorbate against oxidative stress in the mouse lens. Biochim Biophys Acta 1670, 12-18.
46. Huang J, Agus DB, Winfree CJ, Kiss S, Mack WJ, McTaggart RA, Choudhri TF, Kim LJ, Mocco J, Pinsky DJ, Fox WD, Israel RJ, Boyd TA, Golde DW & Connolly ES, Jr. (2001). Dehydroascorbic acid, a blood-brain barrier transportable form of vitamin C, mediates potent cerebroprotection in experimental stroke. Proc Natl Acad Sci U S A 98, 11720-11724.
47. Ito A, Hayashi S & Yoshida T. (1981). Participation of a cytochrome b5-like hemoprotein of outer mitochondrial membrane (OM cytochrome b) in NADHsemidehydroascorbic acid reductase activity of rat liver. Biochem Biophys Res Commun 101, 591-598.
48. Jacques PF & Chylack LT, Jr. (1991). Epidemiologic evidence of a role for the antioxidant vitamins and carotenoids in cataract prevention. Am J Clin Nutr 53, 352S-355S.
49. Jin SN, Mun GH, Lee JH, Oh CS, Kim J, Chung YH, Kang JS, Kim JG, Hwang DH, Hwang YI, Shin DH & Lee WJ. (2005). Immunohistochemical study on the distribution of sodium-dependent vitamin C transporters in the respiratory system of adult rat. Microsc Res Tech 68, 360-367.
50. Kallner AB, Hartmann D & Hornig DH. (1981). On the requirements of ascorbic acid in man: steady-state turnover and body pool in smokers. Am J Clin Nutr 34, 1347-1355.
51. Kang JS, Kim HN, Jung da J, Kim JE, Mun GH, Kim YS, Cho D, Shin DH, Hwang YI & Lee WJ. (2007). Regulation of UVB-induced IL-8 and MCP-1 production in skin keratinocytes by increasing vitamin C uptake via the redistribution of SVCT-1 from the cytosol to the membrane. J Invest Dermatol 127, 698-706.
52. Kannan R, Stolz A, Ji Q, Prasad PD & Ganapathy V. (2001). Vitamin C transport in human lens epithelial cells: evidence for the presence of SVCT2. Exp Eye Res 73, 159-165.
53. Kim M, Otsuka M, Yu R, Kurata T & Arakawa N. (1994). The distribution of ascorbic acid and dehydroascorbic acid during tissue regeneration in wounded dorsal skin of guinea pigs. Int J Vitam Nutr Res 64, 56-59.
54. Kondo Y, Inai Y, Sato Y, Handa S, Kubo S, Shimokado K, Goto S, Nishikimi M, Maruyama N & Ishigami A. (2006). Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci U S A 103, 5723-5728.
55. Korcok J, Dixon SJ, Lo TC & Wilson JX. (2003). Differential effects of glucose on dehydroascorbic acid transport and intracellular ascorbate accumulation in astrocytes and skeletal myocytes. Brain Res 993, 201-207.
56. Korcok J, Wu F, Tyml K, Hammond RR & Wilson JX. (2002). Sepsis inhibits reduction of dehydroascorbic acid and accumulation of ascorbate in astroglial cultures: intracellular ascorbate depletion increases nitric oxide synthase induction and glutamate uptake inhibition. J Neurochem 81, 185-193.
57. Koshizaka T, Nishikimi M, Ozawa T & Yagi K. (1988). Isolation and sequence analysis of a complementary DNA encoding rat liver L-gulono-gamma-lactone oxidase, a key enzyme for L-ascorbic acid biosynthesis. J Biol Chem 263, 1619-1621.
58. Kubin A, Kaudela K, Jindra R, Alth G, Grunberger W, Wierrani F & Ebermann R. (2003). Dehydroascorbic acid in urine as a possible indicator of surgical stress. Ann Nutr Metab 47, 1-5.
59. Kuo SM, MacLean ME, McCormick K & Wilson JX. (2004). Gender and sodiumascorbate transporter isoforms determine ascorbate concentrations in mice. J Nutr 134, 2216-2221.
60. Lee JH, Oh CS, Mun GH, Kim JH, Chung YH, Hwang YI, Shin DH & Lee WJ. (2006). Immunohistochemical localization of sodium-dependent L-ascorbic acid transporter 1 protein in rat kidney. Histochem Cell Biol 126, 491-494.
61. Lee W, Davis KA, Rettmer RL & Labbe RF. (1988). Ascorbic acid status: biochemical and clinical considerations. Am J Clin Nutr 48, 286-290.
62. Leevy CM, Thompson A & Baker H. (1970). Vitamins and liver injury. Am J Clin Nutr 23, 493-499.
63. Lehr HA, Frei B, Olofsson AM, Carew TE & Arfors KE. (1995). Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 91, 1525-1532.
64. Leibovitz B & Siegel BV. (1978). Ascorbic acid, neutrophil function, and the immune response. Int J Vitam Nutr Res 48, 159-164.
65. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J & Cantilena LR. (1996). Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci U S A 93, 3704-3709.
66. Liang WJ, Johnson D & Jarvis SM. (2001). Vitamin C transport systems of mammalian cells. Mol Membr Biol 18, 87-95.
67. Linster CL & Van Schaftingen E. (2003). Rapid stimulation of free glucuronate formation by non-glucuronidable xenobiotics in isolated rat hepatocytes. J Biol Chem 278, 36328-36333.
68. Linster CL & Van Schaftingen E. (2007). Vitamin C. Biosynthesis, recycling and degradation in mammals. FEBS J 274, 1-22.
69. Louw JA, Werbeck A, Louw ME, Kotze TJ, Cooper R & Labadarios D. (1992). Blood vitamin concentrations during the acute-phase response. Crit Care Med 20, 934-941.
70. Lunec J & Blake DR. (1985). The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis (RA). Free Radic Res Commun 1, 31-39.
71. Lutsenko EA, Carcamo JM & Golde DW. (2004). A human sodium-dependent vitamin C transporter 2 isoform acts as a dominant-negative inhibitor of ascorbic acid transport. Mol Cell Biol 24, 3150-3156.
72. MacDonald L, Thumser AE & Sharp P. (2002). Decreased expression of the vitamin C transporter SVCT1 by ascorbic acid in a human intestinal epithelial cell line. Br J Nutr 87, 97-100.
73. Mano Y, Suzuki K, Yamada K & Shimazono N. (1961). Enzymic studies on TPN Lhexonate dehydrogenase from rat liver. J Biochem 49, 618-634.
74. Maulen NP, Henriquez EA, Kempe S, Carcamo JG, Schmid-Kotsas A, Bachem M, Grunert A, Bustamante ME, Nualart F & Vera JC. (2003). Up-regulation and polarized expression of the sodium-ascorbic acid transporter SVCT1 in post-confluent differentiated CaCo-2 cells. J Biol Chem 278, 9035-9041.
75. McNally NJ. (1953). Preliminary report on the use of vitamin C in asthma. Ir Med Assoc 33, 175-178.
76. McNulty AL, Vail TP & Kraus VB. (2005). Chondrocyte transport and concentration of ascorbic acid is mediated by SVCT2. Biochim Biophys Acta 1712, 212-221.
77. Michels AJ, Joisher N & Hagen TM. (2003). Age-related decline of sodium-dependent ascorbic acid transport in isolated rat hepatocytes. Arch Biochem Biophys 410, 112-120.
78. Mori T, Ishigami A, Seyama K, Onai R, Kubo S, Shimizu K, Maruyama N & Fukuchi Y. (2004). Senescence marker protein-30 knockout mouse as a novel murine model of senile lung. Pathol Int 54, 167-173.
79. Mun GH, Kim MJ, Lee JH, Kim HJ, Chung YH, Chung YB, Kang JS, Hwang YI, Oh SH, Kim JG, Hwang DH, Shin DH & Lee WJ. (2006). Immunohistochemical study of the distribution of sodium-dependent vitamin C transporters in adult rat brain. J Neurosci Res 83, 919-928.
80. Naidu KA. (2003). Vitamin C in human health and disease is still a mystery? An overview. Nutr J 2, 7.
81. Ng LL, Ngkeekwong FC, Quinn PA & Davies JE. (1998). Uptake mechanisms for ascorbate and dehydroascorbate in lymphoblasts from diabetic nephropathy and hypertensive patients. Diabetologia 41, 435-442.
82. Nishikimi M, Kawai T & Yagi K. (1992). Guinea pigs possess a highly mutated gene for L-gulono-gamma-lactone oxidase, the key enzyme for L-ascorbic acid biosynthesis missing in this species. J Biol Chem 267, 21967-21972.
83. Obrosova IG, Fathallah L, Liu E & Nourooz-Zadeh J. (2003). Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid. Free Radic Biol Med 34, 186-195.
84. Obrosova IG, Fathallah L & Stevens MJ. (2001). Taurine counteracts oxidative stress and nerve growth factor deficit in early experimental diabetic neuropathy. Exp Neurol 172, 211-219.
85. Ohta Y, Kongo M, Sasaki E, Ishiguro I & Harada N. (2000). Protective effect of melatonin against alpha-naphthylisothiocyanate-induced liver injury in rats. J Pineal Res 29, 15-23.
86. Ohta Y & Nishikimi M. (1999). Random nucleotide substitutions in primate nonfunctional gene for L-gulono-gamma-lactone oxidase, the missing enzyme in Lascorbic acid biosynthesis. Biochim Biophys Acta 1472, 408-411.
87. Palmquist BM, Philipson B & Barr PO. (1984). Nuclear cataract and myopia during hyperbaric oxygen therapy. Br J Ophthalmol 68, 113-117.
88. Patak P, Willenberg HS & Bornstein SR. (2004). Vitamin C is an important cofactor for both adrenal cortex and adrenal medulla. Endocr Res 30, 871-875.
89. Paterson CA & O'Rourke MC. (1987). Vitamin C levels in human tears. Arch Ophthalmol 105, 376-377.
90. Pelletier O. (1975). Vitamin C and cigarette smokers. Ann N Y Acad Sci 258, 156-168.
91. Perez MJ, Castano B, Gonzalez-Buitrago JM & Marin JJ. (2007). Multiple protective effects of melatonin against maternal cholestasis-induced oxidative stress and apoptosis in the rat fetal liver-placenta-maternal liver trio. J Pineal Res 43, 130-139.
92. Perez MJ, Castano B, Jimenez S, Serrano MA, Gonzalez-Buitrago JM & Marin JJ. (2008). Role of vitamin C transporters and biliverdin reductase in the dual pro-oxidant and anti-oxidant effect of biliary compounds on the placental-fetal unit in cholestasis during pregnancy. Toxicol Appl Pharmacol 232, 327-336.
93. Qiu S, Li L, Weeber EJ & May JM. (2007). Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J Neurosci Res 85, 1046-1056.
94. Qutob S, Dixon SJ & Wilson JX. (1998). Insulin stimulates vitamin C recycling and ascorbate accumulation in osteoblastic cells. Endocrinology 139, 51-56.
95. Rajan DP, Huang W, Dutta B, Devoe LD, Leibach FH, Ganapathy V & Prasad PD. (1999). Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and transport function. Biochem Biophys Res Commun 262, 762-768.
96. Rath M. (1993). Eradicating heart disease. Health Now, San Franciso, CA. .
97. Rose RC. (1987). Solubility properties of reduced and oxidized ascorbate as determinants of membrane permeation. Biochim Biophys Acta 924, 254-256.
98. Salceda R & Contreras-Cubas C. (2007). Ascorbate uptake in normal and diabetic rat retina and retinal pigment epithelium. Comp Biochem Physiol C Toxicol Pharmacol 146, 175-179.
99. Savini I, Catani MV, Arnone R, Rossi A, Frega G, Del Principe D & Avigliano L. (2007). Translational control of the ascorbic acid transporter SVCT2 in human platelets. Free Radic Biol Med 42, 608-616.
100. Savini I, Rossi A, Pierro C, Avigliano L & Catani MV. (2008). SVCT1 and SVCT2: key proteins for vitamin C uptake. Amino Acids 34, 347-355.
101. Schachter EN & Schlesinger A. (1982). The attenuation of exercise-induced bronchospasm by ascorbic acid. Ann Allergy 49, 146-151.
102. Schectman G, Byrd JC & Gruchow HW. (1989). The influence of smoking on vitamin C status in adults. Am J Public Health 79, 158-162.
103. Schorah CJ, Downing C, Piripitsi A, Gallivan L, Al-Hazaa AH, Sanderson MJ & Bodenham A. (1996). Total vitamin C, ascorbic acid, and dehydroascorbic acid concentrations in plasma of critically ill patients. Am J Clin Nutr 63, 760-765.
104. Schorah CJ, Sobala GM, Sanderson M, Collis N & Primrose JN. (1991). Gastric juice ascorbic acid: effects of disease and implications for gastric carcinogenesis. Am J Clin Nutr 53, 287S-293S.
105. Seno T, Inoue N, Matsui K, Ejiri J, Hirata K, Kawashima S & Yokoyama M. (2004). Functional expression of sodium-dependent vitamin C transporter 2 in human endothelial cells. J Vasc Res 41, 345-351.
106. Simon JA, Hudes ES & Tice JA. (2001). Relation of serum ascorbic acid to mortality among US adults. J Am Coll Nutr 20, 255-263.
107. Simpson GL & Ortwerth BJ. (2000). The non-oxidative degradation of ascorbic acid at physiological conditions. Biochim Biophys Acta 1501, 12-24.
108. Sinclair AJ, Girling AJ, Gray L, Lunec J & Barnett AH. (1992). An investigation of the relationship between free radical activity and vitamin C metabolism in elderly diabetic subjects with retinopathy. Gerontology 38, 268-274.
109. Siushansian R, Tao L, Dixon SJ & Wilson JX. (1997). Cerebral astrocytes transport ascorbic acid and dehydroascorbic acid through distinct mechanisms regulated by cyclic AMP. J Neurochem 68, 2378-2385.
110. Sobala GM, Pignatelli B, Schorah CJ, Bartsch H, Sanderson M, Dixon MF, Shires S, King RF & Axon AT. (1991). Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach. Carcinogenesis 12, 193-198.
111. Sobala GM, Schorah CJ, Sanderson M, Dixon MF, Tompkins DS, Godwin P & Axon AT. (1989). Ascorbic acid in the human stomach. Gastroenterology 97, 357-363.
112. Spielholz C, Golde DW, Houghton AN, Nualart F & Vera JC. (1997). Increased facilitated transport of dehydroascorbic acid without changes in sodium-dependent ascorbate transport in human melanoma cells. Cancer Res 57, 2529-2537.
113. Steiling H, Longet K, Moodycliffe A, Mansourian R, Bertschy E, Smola H, Mauch C & Williamson G. (2007). Sodium-dependent vitamin C transporter isoforms in skin: Distribution, kinetics, and effect of UVB-induced oxidative stress. Free Radic Biol Med 43, 752-762.
114. Stratakis CA, Taymans SE, Daruwala R, Song J & Levine M. (2000). Mapping of the human genes (SLC23A2 and SLC23A1) coding for vitamin C transporters 1 and 2 (SVCT1 and SVCT2) to 5q23 and 20p12, respectively. J Med Genet 37, E20.
115. Subramanian VS, Marchant JS, Reidling JC & Said HM. (2008). N-Glycosylation is required for Na+-dependent vitamin C transporter functionality. Biochem Biophys Res Commun 374, 123-127.
116. Taylor A, Jacques PF, Nadler D, Morrow F, Sulsky SI & Shepard D. (1991). Relationship in humans between ascorbic acid consumption and levels of total and reduced ascorbic acid in lens, aqueous humor, and plasma. Curr Eye Res 10, 751-759.
117. Trout DL. (1991). Vitamin C and cardiovascular risk factors. Am J Clin Nutr 53, 322S-325S.
118. Tsukaguchi H, Tokui T, Mackenzie B, Berger UV, Chen XZ, Wang Y, Brubaker RF & Hediger MA. (1999). A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature 399, 70-75.
119. Vaquero J, Marin JJ, Hierro C, Monte MJ, Jiménez F, González San-Martin F, Blázquez AG & Macias RR. (2009). Cellular heterogeneity in the expression of vitamin c transporters (SVCT1 and SVCT2) in normal and pathological liver parenchyma. J Hepatology 50: 1: S52.
120. Varma SD. (1987). Ascorbic acid and the eye with special reference to the lens. Ann N Y Acad Sci 498, 280-306.
121. Vera JC, Rivas CI, Zhang RH & Golde DW. (1998). Colony-stimulating factors signal for increased transport of vitamin C in human host defense cells. Blood 91, 2536-2546.
122. Wang H, Dutta B, Huang W, Devoe LD, Leibach FH, Ganapathy V & Prasad PD. (1999). Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant. Biochim Biophys Acta 1461, 1-9.
123. Wang Y, Mackenzie B, Tsukaguchi H, Weremowicz S, Morton CC & Hediger MA. (2000). Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem Biophys Res Commun 267, 488-494.
124. Weber C, Erl W, Weber K & Weber PC. (1996). Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 93, 1488-1492.
125. Whitaker MJ. (1985). Reversing heart disease. Warner Books, New York.
126. Will JC & Byers T. (1996). Does diabetes mellitus increase the requirement for vitamin C? Nutr Rev 54, 193-202.
127. Wilson JX. (2005). Regulation of vitamin C transport. Annu Rev Nutr 25, 105-125.
128. Winkelman J & Lehninger AL. (1958). Aldono- and uronolactonases of animal tissues. J Biol Chem 233, 794-799.
129. Wu X, Itoh N, Taniguchi T, Hirano J, Nakanishi T & Tanaka K. (2004). Stimulation of differentiation in sodium-dependent vitamin C transporter 2 overexpressing MC3T3-E1 osteoblasts. Biochem Biophys Res Commun 317, 1159-1164.
130. Wu X, Itoh N, Taniguchi T, Nakanishi T & Tanaka K. (2003a). Requirement of calcium and phosphate ions in expression of sodium-dependent vitamin C transporter 2 and osteopontin in MC3T3-E1 osteoblastic cells. Biochim Biophys Acta 1641, 65-70.
131. Wu X, Itoh N, Taniguchi T, Nakanishi T, Tatsu Y, Yumoto N & Tanaka K. (2003b). Zinc-induced sodium-dependent vitamin C transporter 2 expression: potent roles in osteoblast differentiation. Arch Biochem Biophys 420, 114-120.